Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
502.60
+4.45 (+0.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
44
45
Next >
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
December 01, 2023
It's not as long a shot as some might think.
Via
The Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
December 01, 2023
These stocks offer enormous long-term growth potential.
Via
The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments.
Via
InvestorPlace
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.
Via
InvestorPlace
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
Via
Talk Markets
5 Stocks You Can Confidently Invest $500 In Right Now
November 27, 2023
These companies could significantly grow your investment over the long haul.
Via
The Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Now?
November 16, 2023
The company is close to another breakthrough.
Via
The Motley Fool
How Is The Market Feeling About Vertex Pharmaceuticals?
November 14, 2023
Via
Benzinga
2 Healthcare Stocks That Could Help Set You Up for Life
November 25, 2023
Both companies are leaders in their fields.
Via
The Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
November 25, 2023
These innovators should have tremendous long-term growth prospects.
Via
The Motley Fool
4 First-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 25, 2023
The innovation-fueled Nasdaq Composite is still 11% below its all-time high, which means bargains abound for opportunistic investors.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Prediction: 3 Stocks That Could Trounce the Market
November 23, 2023
These stocks have what it takes to be huge winners over the next several years.
Via
The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
Many biotech stocks offer exciting long-term growth prospects.
Via
The Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
November 21, 2023
Via
Benzinga
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
November 20, 2023
Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio?
Via
The Motley Fool
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?
November 19, 2023
The stock is trading below its peak, reached a couple of years ago.
Via
The Motley Fool
Barron's Weekend Stock Picks: Disney, Palantir And Cisco's Calamitous Outlook
November 18, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Why CRISPR Therapeutics Stock Is Jumping Again Today
November 17, 2023
The stock continues to enjoy momentum from a key regulatory approval.
Via
The Motley Fool
Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling
November 17, 2023
The Nasdaq 100 closed higher by 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug
November 16, 2023
The drug will sell under the brand name Casgevy in the UK for two blood diseases.
Via
Investor's Business Daily
What's Going On With Crispr Therapeutics Stock Thursday?
November 16, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-
Via
Benzinga
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
November 16, 2023
CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.
Via
InvestorPlace
Exposures
Product Safety
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
November 16, 2023
The U.K.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks
November 14, 2023
You might not get a better chance to invest in these disruptive companies.
Via
The Motley Fool
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
These stocks look reasonably priced today considering their long-term prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
November 12, 2023
Most stocks aren't truly revolutionary. These really are.
Via
The Motley Fool
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
This company has been in the news for much of the year.
Via
The Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
Investors shouldn't have to deliberate for too long about these great stocks.
Via
The Motley Fool
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 11, 2023
A 15% decline in the Nasdaq Composite is a red-carpet opportunity for investors to snag high-quality growth stocks at a discount.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.